Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer.
暂无分享,去创建一个
Alex Y Strongin | A. Strongin | Roy M. Williams | S. Krajewski | Kang Liu | D. Rozanov | Stan Krajewski | A. Savinov | V. Golubkov | Dmitri V Rozanov | Alexei Y Savinov | Roy Williams | Kang Liu | Vladislav S Golubkov
[1] O. Kassel,et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.
[2] Chen Dong,et al. MAP kinases in the immune response. , 2002, Annual review of immunology.
[3] A. Strongin,et al. Tissue Inhibitor of Metalloproteinases-2 Binding to Membrane-type 1 Matrix Metalloproteinase Induces MAPK Activation and Cell Growth by a Non-proteolytic Mechanism* , 2008, Journal of Biological Chemistry.
[4] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[5] T. Poggio,et al. Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] John Calvin Reed,et al. Claudin‐1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate , 2007, The Prostate.
[7] A. Strongin,et al. Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells. , 2004, Experimental cell research.
[8] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[9] T. Isobe,et al. Membrane Type 1 Matrix Metalloproteinase (MT1-MMP/MMP-14) Cleaves and Releases a 22-kDa Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Fragment from Tumor Cells* , 2006, Journal of Biological Chemistry.
[10] R. Fridman,et al. Processing, shedding, and endocytosis of membrane type 1‐matrix metalloproteinase (MT1‐MMP) , 2004, Journal of cellular physiology.
[11] O. Kallioniemi,et al. Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients , 2004, Clinical Cancer Research.
[12] A. Strongin,et al. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. , 2002, Cancer research.
[13] K. Yoshioka,et al. Membrane Type 1 Matrix Metalloproteinase Regulates Collagen-Dependent Mitogen-Activated Protein/Extracellular Signal-Related Kinase Activation and Cell Migration , 2004, Cancer Research.
[14] O. Issinger,et al. Protein kinase CK2 and its role in cellular proliferation, development and pathology , 1999, Electrophoresis.
[15] F. Ashcroft,et al. Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion. , 2006, Cell metabolism.
[16] M. Hendrix,et al. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. , 2003, Cancer research.
[17] L. Pinna,et al. Protein kinase CK2. , 2013, The international journal of biochemistry & cell biology.
[18] J. Hogg,et al. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. , 1994, Cancer research.
[19] S. Varambally,et al. JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence , 2004, Cancer Research.
[20] S. Weiss,et al. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. , 2006, Genes & development.
[21] Khalil Ahmed. Significance of the casein kinase system in cell growth and proliferation with emphasis on studies of the androgenic regulation of the prostate. , 1994, Cellular & molecular biology research.
[22] Y. Itoh,et al. MT1‐MMP: A key regulator of cell migration in tissue , 2006, IUBMB life.
[23] Stephen J. Weiss,et al. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] Qiang Zhou,et al. Stimulatory effect of splicing factors on transcriptional elongation , 2001, Nature.
[25] S. Bourgeois,et al. Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts , 1983, Cell.
[26] H. Nagasawa,et al. Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner. , 2006, International journal of oncology.
[27] O. Issinger,et al. Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. , 1990, European journal of biochemistry.
[28] A. Strongin,et al. The Hemopexin-like C-terminal Domain of Membrane Type 1 Matrix Metalloproteinase Regulates Proteolysis of a Multifunctional Protein, gC1qR* , 2002, The Journal of Biological Chemistry.
[29] L. Ellerby,et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Strongin,et al. Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells. , 2006, Cancer research.
[31] D. Hanahan,et al. A transition in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma development. , 1995, The EMBO journal.
[32] A. Strongin,et al. Mutation Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) , 2001, The Journal of Biological Chemistry.
[33] Hiroshi Sato,et al. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration. , 2006, Experimental cell research.
[34] A. Ruifrok,et al. Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.
[35] M. Bernardo,et al. Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation* , 2000, The Journal of Biological Chemistry.
[36] Stefanie S Jeffrey,et al. A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue , 2004, BMC Genomics.
[37] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[38] Y. Sadovsky,et al. N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury* , 2006, Journal of Biological Chemistry.
[39] A. Strongin,et al. Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice. , 2006, Cancer research.
[40] J. Hériché,et al. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. , 1997, Science.
[41] Yi Xing,et al. ASAP: the Alternative Splicing Annotation Project , 2003, Nucleic Acids Res..
[42] A. Strongin,et al. O-Glycosylation Regulates Autolysis of Cellular Membrane Type-1 Matrix Metalloproteinase (MT1-MMP)* , 2006, Journal of Biological Chemistry.
[43] K. Ahmed,et al. Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation. , 1996, Cancer letters.
[44] I. Pettersson,et al. U2‐SnRNP B″ protein gene is an early growth‐inducible gene , 1995, Journal of cellular biochemistry.
[45] E. Thompson,et al. The promoter and first, untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor element sites , 1990, Molecular and cellular biology.
[46] L. Pinna,et al. Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation. , 1997, Progress in cell cycle research.
[47] J. Gutkind,et al. MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D* , 2007, Journal of Biological Chemistry.
[48] Munirah Ahmad,et al. Cleavage of Lumican by Membrane-Type Matrix Metalloproteinase-1 Abrogates This Proteoglycan-Mediated Suppression of Tumor Cell Colony Formation in Soft Agar , 2004, Cancer Research.
[49] Y. Okada,et al. Constitutive and Induced CD44 Shedding by ADAM-Like Proteases and Membrane-Type 1 Matrix Metalloproteinase , 2004, Cancer Research.
[50] A. Strongin,et al. Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Exhibits an Important Intracellular Cleavage Function and Causes Chromosome Instability* , 2005, Journal of Biological Chemistry.
[51] J. Keski‐Oja,et al. Co-recycling of MT1-MMP and MT3-MMP through the Trans-Golgi Network , 2004, Journal of Biological Chemistry.